Since the whole human genome sequence has become available, the methods to search for genes of diseases or drugs responses (traits) have changed dramatically. The former approach designated as``candidate gene approach'' is now dominated by``genome-wide approach''. In the former approach, researchers search for the genes based on the functions using biochemistry and molecular biology; however, in the latter approach, the genes are searched for by the genetic and statistical methods. Initially, monogenic diseases were the targets of the researches; however, polygenic diseases and drug responses have become the targets. Parametric linkage analysis was quite useful for identifying responsible genes for monogenic diseases. Genome-wide association study (GWAS) has been introduced for the identiˆcation of the genes for polygenic diseases and drug responses. GWAS wasˆrst introduced from 2002 to 2004 in Center for Genomic Medicine, RIKEN but has expanded rapidly to other countries including US, Europe and Asian countries from 2005. In Nature Genetics journal, about half of the articles published recently include the data from GWAS studies. Both qualitative and quantitative traits have been analyzed by GWAS. Qualitative traits include diseases and drug responses and quantitative traits include physical measures and clinical laboratory test values. Recent reports about the association between drug responses and genes have clariˆed many important pharmacogenomic associations. For these data to be analyzed e‹ciently and used appropriately; however, guidelines for researches and clinical tests concerning pharmacogenomics (PGx) are necessary.``Guideline for pharmacogenomic test'' was issued in 2009 and, in addition, an extended guideline covering variousˆelds is now being discussed.
. EŠects of Genetic and Environmental Factors on Diseases
There are both genetic and environmental factors for diseases, and the proportions of the factors vary between both diseases and individuals. An example of a disease with only genetic factors is a genetic disease, and that with only environmental factors is an injury. The strength of the eŠect of each gene on the disease is expressed as an eŠect size. Except for genetic diseases that are located at the right end, the eŠects of genes on diseases should be studied quantitatively rather than qualitatively. DNA is collected from many cases and controls, and the genotypes at about 500000 SNPs are obtained. Subsequently, the data are analyzed by algorithms based on statistical genetics, and the SNPs signiˆcantly associated with a disease are searched for. The distinction between cases and controls does not exist for quantitative traits.
Fig. 3. Change in the Proportion of GWAS-related Papers in Nature Genetics
The number of papers using the data from GWAS is rapidly increasing. Clinical laboratory data are interpreted as phenotypes and GWAS was performed using the data from about 14700 Japan Biobank samples. Only the results about urate, BUN and creatinine are shown. These plots are called Manhattan plots that indicate -log P values for the associations between SNP genotypes and phenotypes for about 500000 SNPs arranged in order from chr 1 to 22 (or X chromosome) from left to right. In the analysis, various covariates were used for the adjustment and meta-analysis was performed using the inverse variance method. The red horizontal line shows the genome-wide signiˆcance level of 5×10 -8 , and the plots higher than this level are considered to be signiˆcant (From Ref. 
